质氨酸在跨导管大动脉置换中预防并发症的有效性和安全性:一个元分析
Tanawat Attachaipanich1, Suthinee Attachaipanich2, Kotchakorn Kaewboot3
1Department of Internal Medicine, Kansas City School of Medicine, University of Missouri, Kansas City, MO, USA.
Minerva cardiology and angiology
|August 1, 2025
概括
在过导管大动脉置换术 (TAVR) 后服用前列腺素显著减少出血和血管并发症. 这一元分析证实了它的安全性,并没有显示TAVR患者中风或心肌梗塞的风险增加.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 过导管大动脉置换 (TAVR) 是一个不断增长的手术,出血和血管并发症的发病率显著.
- 目前关于TAVR后蛋白质胺使用的指导方针尚未明确,这在临床实践中造成了不确定性.
研究的目的:
- 在TAVR后的患者中系统评估前胺的疗效和安全性.
- 在TAVR后的环境中评估前胺对出血和血管并发症的影响.
主要方法:
- 使用来自PubMed,Embase,Web of Science和Cochrane CENTRAL的数据进行了全面的元分析.
- 六项研究,包括两项随机和四项非随机试验,共3897名参与者,使用随机效应模型进行了分析.
主要成果:
- 质氨酸显著降低了TAVR后主要出血 (OR 0.47;P<0.01) 和主要血管并发症 (OR 0.45;P<0.01) 的风险.
- 随着蛋白质胺使用,观察到轻微和危及生命的出血风险降低.
- 蛋白胺的使用与中风或心肌梗塞的风险增加无关.
结论:
- 质氨酸在缓解TAVR后期出血和血管并发症方面是有效的.
- 蛋白胺的使用不会增加血栓栓塞事件的风险,支持其在这个患者群体中的安全性.
相关概念视频
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
646
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
646
Anticoagulant Drugs: Low-Molecular-Weight Heparins
911
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
911
Cardiac Catheterization I: Pre-Procedure Overview
160
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
160
Cardiac Catheterization IV: Nursing Management
193
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
193


